Lantern Pharma Inc. (LTRN) News
Track canonical SquawkNews coverage tagged to LTRN, Lantern Pharma Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASD
New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASDAQ: CAST), Metaterra Holdings (MTHI) and SafeSpace Global (SGCC)
EQUITY | Aug 29, 2026, 01:22 PM UTC
L
LTRN Lantern Pharma to advance EMA-cleared phase 1B/2 trial of lp-184 (zirdafulven) in biomarker-selected advanced bladder cancer
LTRN Lantern Pharma to advance EMA-cleared phase 1B/2 trial of lp-184 (zirdafulven) in biomarker-selected advanced bladder cancer
EQUITY | Jul 28, 2026, 11:45 AM UTC
H
Lantern Pharma Launches ZetaOmics, A Computational-Biology Module Of Its WithZeta.ai Co-Scientist Platform
ZetaOmics introduces an autonomous "Computational Biologist" persona (agent) that performs real, end-to-end bioinformatics and multi-omic analysis — across any cancer type, and is purpose-built for the rare and pediatric
EARNINGS | Jul 08, 2026, 11:33 AM UTC